Condensed Statements of Operations (unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Income Statement [Abstract] | ||||||
| Revenues | ||||||
| Operating expenses: | ||||||
| Research and development | 178,862 | 1,186,900 | 1,199,601 | 2,693,208 | 5,935,718 | 7,705,090 |
| General and administrative | 4,254,487 | 1,556,785 | 5,533,760 | 3,301,703 | 6,452,579 | 7,703,065 |
| Total operating expenses | 4,433,349 | 2,743,685 | 6,733,361 | 5,994,911 | 12,388,297 | 15,408,155 |
| Operating loss | (4,433,349) | (2,743,685) | (6,733,361) | (5,994,911) | (12,388,297) | (15,408,155) |
| Other income (expense): | ||||||
| Interest income | 100,997 | 18,717 | 235,158 | 18,717 | 223,291 | 5,578 |
| Interest expense | (1,824) | (1,479) | (40,108) | |||
| Amortization of debt discount and offering costs | (8,723) | (8,723) | (33,091) | |||
| Total other income | 100,997 | 18,717 | 235,158 | 8,170 | 213,089 | (67,621) |
| Net loss | $ (4,332,352) | $ (2,724,968) | $ (6,498,203) | $ (5,986,741) | $ (12,175,208) | $ (15,475,776) |
| Basic net loss per share (in Dollars per share) | $ (1.49) | $ (0.94) | $ (2.24) | $ (2.07) | $ (4.2) | $ (6.97) |
| Weighted average common shares outstanding – basic (in Shares) | 2,906,926 | 2,899,390 | 2,906,926 | 2,895,158 | 2,900,202 | 2,220,981 |
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of accretion (amortization) of purchase discount (premium) on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|